References
- CDC/HCHS. National vital statistics system, mortality 2015 [Internet]; 2017 [cited Apr 19]. Available from: https://www.cdc.gov/nchs/data/dvs/LCWK1_2015.pdf.
- Our World in Data. Causes of death [Internet]; 2018 [cited 2020 Apr 19]. Available from: https://ourworldindata.org/causes-of-death.
- Dorsey ER, Elbaz A, Nichols E, et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–953.
- Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896–912.
- Emamzadeh FN, Surguchov A. A Parkinson’s disease: biomarkers, treatment, and risk factors. Front Neurosci. 2018;12:612.
- Gibson G, Kierans C. Ageing, masculinity and Parkinson’s disease: embodied perspectives. Sociol Health Illn. 2017;39(4):532–546.
- Hindle JV. Ageing, neurodegeneration and Parkinson's disease. Age Ageing. 2010;39(2):156–161.
- Moustafa AA, Chakravarthy S, Phillips JR, et al. Motor symptoms in Parkinson's disease: a unified framework. Neurosci Biobehav Rev. 2016;68:727–740.
- Chaudhuri KR, Odin P, Antonini A, et al. Parkinson's disease: the non-motor issues. Parkinsonism Relat Disord. 2011;17(10):717–723.
- Prakash KM, Nadkarni NV, Lye WK, et al. The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study. Eur J Neurol. 2016;23(5):854–860.
- Parkinson’s Foundation. Statistics [Internet]; 2016 [cited 2020 July 12]. Available from: https://www.parkinson.org/Understanding-Parkinsons/Statistics.
- Aarsland D, Cummings J, Weintraub D, et al. Neuropsychiatric and cognitive changes in Parkinson’s disease and related movement disoders. New York (NY): Cambridge University Press; 2013.
- Haahr A, Kirkevold M, Hall EO, et al. Living with advanced Parkinson's disease: a constant struggle with unpredictability. J Adv Nurs. 2011;67(2):408–417.
- Backstrom D, Granasen G, Domellof ME, et al. Early predictors of mortality in Parkinsonism and Parkinson disease: a population-based study. Neurology. 2018;91(22):e2045–e2056.
- Chang YP, Yang CJ, Hu KF, et al. Risk factors for pneumonia among patients with Parkinson’s disease: a Taiwan nationwide population-based study. Neuropsychiatr Dis Treat. 2016;12:1037–1046.
- Auyeung M, Tsoi TH, Mok V, et al. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients. J Neurol Neurosurg Psychiatry. 2012;83(6):607–611.
- Hobson P, Meara J. Mortality and quality of death certification in a cohort of patients with Parkinson’s disease and matched controls in North Wales, UK at 18 years: a community-based cohort study. BMJ Open. 2018;8(2):e018969.
- CBC. The Canadian Press. Changes needed to boost end-of-life care in Canada: doctors [Interent]; 2016 [cited 2019 Nov 23]. Available from: https://www.cbc.ca/news/health/canada-end-of-life-care-improvements-1.3731900.
- World Health Organization. Palliative care [Internet]; 2018 [cited May 4]. Available from: https://www.who.int/news-room/fact-sheets/detail/palliative-care.
- Tarolli CG, Holloway RG. Palliative care and Parkinson’s disease: outpatient needs and models of care over the disease trajectory. Ann Palliat Med. 2020;9(Suppl 1):S44–S51.
- Bouça-Machado R, Lennaerts-Kats H, Bloem B, et al. Why palliative care applies to Parkinson's disease. Mov Disord. 2018;33(5):750–753.
- Boersma I, Miyasaki J, Kutner J, et al. Palliative care and neurology: time for a paradigm shift. Neurology. 2014;83(6):561–567.
- Grimes D, Fitzpatrick M, Gordon J, et al. Canadian guideline for Parkinson disease. CMAJ. 2019;191(36):E989–E1004.
- Miyasaki JM, Long J, Mancini D, et al. Palliative care for advanced Parkinson’s disease: an interdisiplinary clinic and new scale, the ESAS-PD. Parkinsonism Relat Disord. 2012;18:S6–S9.
- Ng JS. Palliative care for Parkinson’s disease. Ann Palliat Med. 2018;7(3):296–303.
- Kluger BM, Miyasaki J, Katz M, et al. Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial. JAMA Neurol. 2020;77(5):551–560.
- Veronese S, Gallo G, Valle A, et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Support Palliat Care. 2017;7(2):164–172.
- Lokk J, Delbari A. Clinical Aspects of palliative care in advanced parkinson’s disease. BMC Palliat Care. 2012;11:20.
- Greenwell K, Gray WK, van Wersch A, et al. Predictors of the psychosocial impact of being a carer of people living with Parkinson’s disease: a systematic review, Parkinsonism & related disorders. Parkinsonism Relat Disord. 2015;21(1):1–11.
- Abendroth M, Lutz BJ, Young ME. Family caregivers' decision process to institutionalize persons with Parkinson's disease: a grounded theory study. Int J Nurs Stud. 2012;49(4):445–454.
- Lennaerts H, Steppe M, Munneke M, et al. Palliative care for persons with Parkinson's disease: a qualitative study on the experiences of health care professionals. BMC Palliat Care. 2019;18(1):53.
- Kozlov E, Reid MC, Carpenter BD. Improving patient knowledge of palliative care: a randomized controlled intervention study. Patient Educ Couns. 2017;100(5):1007–1011.
- Kluger BM, Fox S, Timmons S, et al. Palliative care and Parkinson's disease: meeting summary and recommendations for clinical research. Parkinsonism Relat Disord. 2017;37:19–26.
- Strand JJ, Kamdar MM, Carey EC. Top 10 things palliative care clinicians wished everyone knew about palliative care. Mayo Clin Proc. 2013;88(8):859–865.
- Aparicio M, Centeno C, Carrasco JM, et al. What are families most grateful for after receiving palliative care? Content analysis of written documents received: a chance to improve the quality of care. BMC Palliat Care. 2017;16(1):47.
- Holm M, Carlander I, Fürst CJ, et al. Delivering and participating in a psycho-educational intervention for family caregivers during palliative home care: a qualitative study from the perspectives of health professionals and family caregivers. BMC Palliat Care. 2015;14:16.
- Lee GB, Woo H, Lee SY, et al. The burden of care and the understanding of disease in Parkinson’s disease. PLoS One. 2019;14(5):e0217581.
- The Gold Standards Framework. The GSF Prognostic Indicator Guidance [Internet]; 2011 [cited 2019 Dec 10]. Available from: https://www.goldstandardsframework.org.uk/cd-content/uploads/files/General%20Files/Prognostic%20Indicator%20Guidance%20October%202011.pdf.
- Canadian Hospice Palliative Care Association. The way forward: an integrated palliative approach to care [Internet]. 2012 [cited 2021 Jan 12]. Available from: http://www.hpcintegration.ca/media/36315/TWF-integrating-palliative-approach-report-Eng_final3.pdf.
- American Academy of Hospice and Palliative Medicine. A profile of new hopsice and palliative medicine and physicians [Internet]; 2017 [cited 2020 July 15]. Available from: http://aahpm.org/uploads/Profile_of_New_HPM_Physicians_2016_Executive_Summary_January_2017.pdf.
- Lupu D, Quigley L, Mehfoud N, et al. The growing demand for hospice and palliative medicine physicians: will the supply keep up? J Pain Symptom Manage. 2018;55(4):1216–1223.
- Dai YX, Chen TJ, Lin MH. Branding palliative care units by avoiding the terms "palliative" and "hospice". Inquiry. 2017;54:46958016686449.
- Quill TE, Abernethy AP. Generalist plus specialist palliative care–creating a more sustainable model. N Engl J Med. 2013;368(13):1173–1175.
- Creutzfeldt CJ, Kluger B, Kelly AG, et al. Neuropalliative care: priorities to move the field forward. Neurology. 2018;91(5):217–226.
- Glover TL, Kluger BM. Palliative medicine and end-of-life care. Handb Clinc Neurol. 2019;167:545–561.
- Creutzfeldt CJ, Robinson MT, Holloway RG. Neurologists as primary palliative care providers: communication and practice approaches. Neurol Clin Pract. 2016;6(1):40–48.
- Moens K, Houttekier D, Van den Block L, et al. Place of death of people living with Parkinson's disease: a population-level study in 11 countries. BMC Palliat Care. 2015;14:28.
- Victoria Hospice Society. Palliative Performance Scale (PPSv2) [Internet]; 2001 [cited 2019 Dec 2]. Available from: http://www.npcrc.org/files/news/palliative_performance_scale_PPSv2.pdf.
- Creber RM, Russell D, Dooley F, et al. Use of the Palliative Performance Scale to estimate survival among home hospice patients with heart failure. ESC Heart Fail. 2019;6(2):371–378.
- Anderson F, Downing GM, Hill J, et al. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12(1):5–11.
- National Hospice and Palliative Care Organization. A palliative care approach to parkinson’s and other neurodegenerative diseases [Internet]; 2017 [cited 2020 July 16]. Available from: https://silo.tips/download/a-palliative-care-approach-to-parkinson-s-and-other-neurodegenerative-diseases.
- Goy ER, Bohlig A, Carter J, et al. Identifying predictors of hospice eligibility in patients with Parkinson disease. Am J Hosp Palliat Care. 2015;32(1):29–33.
- White N, Kupeli N, Vickerstaff V, et al. How accurate is the ‘Surprise Question’ at identifying patients at the end of life? A systematic review and meta-analysis. BMC Med. 2017;15(1):139.
- Rietjens JA, Sudore RL, Connolly M, et al. Definition and recommendations for advance care planning: an international consensus supported by the European association for palliative care. Lancet Oncol. 2017;18(9):e543–e551.
- Sudore RL, Lum HD, You JJ, et al. Defining advance care planning for adults: a consensus definition from a multidisciplinary delphi panel. J Pain Symptom Manage. 2017;53(5):821.e1–832.e1.
- Lum HD, Jordan SR, Brungardt A, et al. Framing advance care planning in Parkinson disease: patient and care partner perspectives. Neurology. 2019;92(22):e2571–e2579.
- American Academy of Neurology. Parkinson’s disease quality measurement set update [Internet]; 2015 [cited 2020 May 6]. Available from: https://www.aan.com/siteassets/home-page/policy-and-guidelines/quality/quality-measures/16pdmeasureset_pg.pdf.
- Kwak J, Wallendal MS, Fritsch T, et al. Advance care planning and proxy decision making for patients with advanced parkinson disease. South Med J. 2014;107(3):178–185.
- McCusker M, Ceronsky L, Crone C, et al. Palliative care for adults. Vol. 81. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI). 2013.
- Tuck KK, Brod L, Nutt J, et al. Preferences of patients with Parkinson's disease for communication about advanced care planning. Am J Hosp Palliat Care. 2015;32(1):68–77.
- Boersma I, Jones J, Carter J, et al. Parkinson disease patients' perspectives on palliative care needs: what are they telling us? Neurol Clin Pract. 2016;6(3):209–219.
- National Institute on Aging. Providing care and comfort at the end of life [Internet]; 2017 [cited 2020 May 6]. Available from: https://www.nia.nih.gov/health/providing-comfort-end-life.
- National Institute on Aging. What are palliative care and hospice care [Internet]; 2017 [cited 2020 May 6]. Available from: https://www.nia.nih.gov/health/what-are-palliative-care-and-hospice-care.
- Baycrest. Feeding choices for people with advanced Parkinson’s disease [Internet]; 2016 [cited 2020 May 8]. Available from: https://baycrest.echoontario.ca/wp-content/uploads/2019/03/Feeding_Choices_Advanced_Parkinson_Disease-1.pdf.
- Rome RB, Luminais HH, Bourgeois DA, et al. The role of palliative care at the end of life. Ochsner J. 2011;11(4):348–352.
- Radder DLM, de Vries NM, Riksen NP, et al. Multidisciplinary care for people with Parkinson’s disease: the new kids on the block! Expert Rev Neurother. 2019;19(2):145–157.
- Payne S, Hughes S, Wilkinson J, et al. Recommendations on priorities for integrated palliative care: transparent expert consultation with international leaders for the InSuP-C project. BMC Palliat Care. 2019;18(1):32.
- Cruz-Oliver DM, Little MO, Woo J, et al. End-of-life care in low- and middle-income countries. Bull World Health Organ. 2017;95(11):731.
- Poudel A, Kc B, Shrestha S, et al. Access to palliative care: discrepancy among low-income and high-income countries. J Glob Health. 2019;9(2):020309.